103
Participants
Start Date
March 31, 2016
Primary Completion Date
May 17, 2017
Study Completion Date
May 17, 2017
SANGUINATE™
As needed (PRN) infusions of 500 mL of SANGUINATE
Mt. Sinai /Recanati/Miller Transplantation Institute, Icahn, New York
Northwell - North Shore University Hospital, Lake Success
University of Pittsburgh, Pittsburgh
Abington University, Abington
Hahnemann University Hospital (Rittenhouse), Philadelphia
University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Medstar Georgetown University Hosiptal, Washington D.C.
Johns Hopkins University, Baltimore
Virginia Commonwealth University, Richmond
Presbyterian Hospital Novant Health, Charlotte
Medical University of South Carolina, Charleston
Bon Secour St Francis Cancer Center, Greenville
Wellstar Atlanta Medical Centre, Marietta
Augusta University, Augusta
Tampa General Hospital, Tampa
Brookwood Princeton Baptist, Birmingham
Detroit Medical Center Harper Univesity Hospital, Detroit
Blood Center of Wisconsin, Milwaukee
Houston Methodist Hospital, Houston
St. Lukes, Houston
University of Texas Medical Center (El Paso), El Paso
Yavapai Regional Medical Center, Prescott
City of Hope, Duarte
Providence Holy Cross Hospital, Mission Hills
Kaiser Permanente, Baldwin Park
Loma Linda Medical Center, Loma Linda
Antelope Valley Hospital, Lancaster
Swedish Medical Center, Seattle
Englewood Medical Center, Englewood
Hackensack University Medical Center, Hackensack
St. Barnabas, Livingston
Lead Sponsor
Prolong Pharmaceuticals
INDUSTRY